CoChat

Improved Quality of Glycemic Control and Reduced Glycemic Variability with Use of Continuous Glucose Monitoring

Open access
Rodbard, David, Bailey, Timothy, Jovanovic, Lois, Zisser, Howard, Kaplan, Roy, Garg, Satish K. · 2009 · Diabetes Technology & Therapeutics
Cited by 131

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Abstract

OBJECTIVE: We evaluated effects of unmasking of continuous display of continuous glucose monitoring (CGM) on quality of glycemic control and glycemic variability. METHODS: We reanalyzed CGM data from 85 patients using a 7-day glucose sensor. Glucose values were "masked" during the first week but "unmasked" during the next 2 weeks. We evaluated 48 criteria for quality of glycemic control, including mean glucose, SD, percentage of values within-, above- or below- specified ranges, Schlichtkrull's M(100) index, mean amplitude of glycemic excursion (MAGE), mean of daily differences (MODD), the J index, "Index of Glycemic Control" (IGC), Hyperglycemia Index, Hypoglycemia Index, High Blood Glucose Index (HBGI), Low Blood Glucose Index (LBGI), average daily risk range (ADRR), GRADE scores, and CONGA(n). We calculated SD values between daily means, between days-within time points, within days, between time points (for the average glucose profile for several days), and within series for time segments of arbitrary length. RESULTS: Unmasking CGM displays resulted in rapid, highly statistically significant improvement in 29 indices, including percentage within, percentage above, and percentage below target range, mean glucose, SD, SD of daily means, MODD, M(100), IGC, GRADE, HBGI, and J index. Both hyperglycemia and hypoglycemia improved during the first week after unmasking; further improvement in hypoglycemia was seen during the following week. Results obtained using multiple criteria were consistent and highly correlated. CONCLUSIONS: Continuous access to display of CGM sensors dramatically improved 29 indices of glycemic control and glycemic variability.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1089/dia.2009.0077

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Cited by

See all 131

Metadata

Authors
Rodbard, D., Bailey, T., Jovanovic, L., Zisser, H., Kaplan, R., & Garg, S. K.
Venue
Diabetes Technology & Therapeutics
Published
2009-11
Volume
11
Issue
11
Pages
717-723
ISSN
  • 1520-9156 (ISSN-L)
  • 1557-8593
OpenAlex
W2008908415
Cited by
131
References
4
FWCI
6.31
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Improved Quality of Glycemic Control and Reduced Glycemic Variability with Use of Continuous Glucose Monitoring. https://app.cochat.ai/papers/10.1089/dia.2009.0077
The paper
Rodbard, D., Bailey, T., Jovanovic, L., Zisser, H., Kaplan, R., & Garg, S. K. (2009). Improved Quality of Glycemic Control and Reduced Glycemic Variability with Use of Continuous Glucose Monitoring. Diabetes Technology & Therapeutics. https://doi.org/10.1089/dia.2009.0077

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.